Showing results (811-820 of 999) with videos related to
Sort By:
Pageof 100
Journal of the American Heart Association|January 12, 2017
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart FailureReynaria Pitts, Elise Gunzburger, Christie M Ballantyne, et al.Journal of Clinical Lipidology|March 29, 2022
Efficacy and safety of bempedoic acid in patients not receiving statins in phase 3 clinical trialsUlrich Laufs, Christie M Ballantyne, Maciej Banach, et al.Circulation|March 23, 2011
Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities StudyJustin T Saunders, Vijay Nambi, James A de Lemos, et al.European Journal of Preventive Cardiology|December 13, 2016
Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC studyYashashwi Pokharel, Wensheng Sun, Dennis T Villareal, et al.Clinical Cardiology|March 16, 2017
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention TrialDeepak L Bhatt, Ph Gabriel Steg, Eliot A Brinton, et al.JACC. Heart Failure|June 14, 2025
Differential Associations of Cardiac, Pulmonary, Arterial, and Muscle Physiological Parameters and Biomarkers With the Incidence of HFpEF and HFrEFFernando R Giugni, Yimin Yang, Brian Claggett, et al.Journal of Clinical Lipidology|September 10, 2024
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid AssociationDaniel E Soffer, Nicholas A Marston, Kevin C Maki, et al.Journal of the American College of Cardiology|March 23, 2019
Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-ITDeepak L Bhatt, Ph Gabriel Steg, Michael Miller, et al.The Journal of Applied Laboratory Medicine|October 23, 2019
Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer AssayAdrienne Tin, Bing Yu, Jianzhong Ma, et al.American Heart Journal|December 5, 2016
On-treatment analysis of the Improved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT)Michael A Blazing, Robert P Giugliano, James A de Lemos, et al.Pageof 100